This Article Full Text Full Text (PDF) All Versions of this Article: 112/8/1106    most recent CIRCULATIONAHA.105.534073v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oechslin, E. Articles by Brunner-La Rocca, H. P. Search for Related Content PubMed PubMed Citation Articles by Oechslin, E. Articles by Brunner-La Rocca, H. P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Congenital Heart Defects Hazardous Substances DB OXYGEN Related Collections Pulmonary circulation and disease Endothelium/vascular type/nitric oxide Other Vascular biology Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2005;112:1106-1112.)
© 2005 American Heart Association, Inc.

Congenital Heart Disease

Systemic Endothelial Dysfunction in Adults With Cyanotic Congenital Heart Disease

Erwin Oechslin, MD; Wolfgang Kiowski, MD; Ruth Schindler, RN; Alain Bernheim, MD; Barbara Julius, MD; Hans Peter Brunner-La Rocca, MD

From the CardioVascular Center (E.O., W.K., R.S., A.B., B.J., H.P.B.-L.R.), Division of Cardiology, University Hospital, Zurich, and the CardioVascular Center (W.K.), Klinik im Park, Zurich, and the Division of Cardiology (R.S., A.B., H.P.B.-L.R.), University Hospital, Basel, Switzerland.

Correspondence to E. Oechslin, MD, FESC, CardioVascular Center, Division of Cardiology, Department of Internal Medicine, University Hospital, Raemistrasse 100, 8091 Zurich, Switzerland. E-mail erwin.oechslin{at}usz.ch

Received August 28, 2003; de novo received January 5, 2005; revision received May 16, 2005; accepted May 17, 2005.

Background— Secondary erythrocytosis results in increased shear stress in cyanotic congenital heart disease (CCHD), which may modify the balance between vasodilators and vasoconstrictors and affect systemic endothelial function. Because no data are available on systemic vasomotion, systemic endothelial function and nitric oxide (NO) availability were investigated in CCHD patients.

Methods and Results— Responses to arterial endothelium-dependent (acetylcholine [Ach]) and -independent (sodium nitroprusside [SNP]) vasodilation, NO synthase blockade (N^G-monomethyl-L-arginine [L-NMMA]), endothelin-1 (ET-1), and ET-1 receptor blockade by BQ-123 in 11 CCHD patients (O₂ saturation <90%; mean±SD, 79±1%; mean±SD age, 39±2 years) were compared with those in 10 age-matched healthy referents by using forearm venous occlusion plethysmography. Resting forearm blood flow (FBF) was lower in CCHD patients than in referents (2.4±0.2 versus 3.5±0.4 mL · min^–1 · 100 mL^–1 of forearm volume [FAV], P<0.05). Although the response to SNP was similar in both groups (CCHD, 2.0±0.3 to 8.3±1.0; referents, 3.6±0.7 to 11.9±1.2 mL · min^–1 · 100 mL^–1 of FAV; P>0.1), the response to Ach was markedly reduced in CCHD (maximal increase in FBF, 2.8±0.8 versus 37.5±4.4 mL · min^–1 · 100 mL^–1 of FAV; P<0.0001). L-NMMA was less effective in CCHD (decrease in FBF, 25±6% versus 40±4%; P<0.05). ET-1 caused less vasoconstriction in the CCHD group (–25±9% versus –51±7%, P<0.05), but the response to BQ-123 was similar in both groups (32±9% versus 27±9%).

Conclusions— Systemic endothelial dysfunction is evident in CCHD patients as shown by strikingly reduced endothelial vasodilation to Ach. The response to exogenous ET-1 is reduced, possibly because of elevated endogenous ET-1 levels, but the effects of endogenous ET-1 on arterial tone are not enhanced, as indicated by the similar response to ET-1 blockade.

Key Words: heart defects, congenital • cyanosis • endothelium • microcirculation • hemoglobin

This article has been cited by other articles:

				G.-P. Diller, S. van Eijl, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bedard, J. S. R. Gibbs, J. Bauersachs, et al. Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension Circulation, June 10, 2008; 117(23): 3020 - 3030. [Abstract] [Full Text] [PDF]

				G.-P. Diller, K. Dimopoulos, H. Kafka, S. Y. Ho, and M. A. Gatzoulis Model of chronic adaptation: right ventricular function in Eisenmenger syndrome Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H54 - H60. [Abstract] [Full Text] [PDF]

				G.-P. Diller and M. A. Gatzoulis Pulmonary Vascular Disease in Adults With Congenital Heart Disease Circulation, February 27, 2007; 115(8): 1039 - 1050. [Abstract] [Full Text] [PDF]

				E. I. Dedkov, J. K. Perloff, R. J. Tomanek, M. C. Fishbein, and D. D. Gutterman The Coronary Microcirculation in Cyanotic Congenital Heart Disease Circulation, July 18, 2006; 114(3): 196 - 200. [Abstract] [Full Text] [PDF]